Blum, J <br/><br/>
Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis.  [electronic resource] 

 -  Tropical medicine & international health : TM & IH  May 2001 
 - 390-400 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1360-2276 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-3156.2001.00710.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angola<br/>Central Nervous System Protozoal Infections--chemically induced<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Melarsoprol--administration & dosage<br/>Middle Aged<br/>Predictive Value of Tests<br/>Risk Factors<br/>Syndrome<br/>Time Factors<br/>Treatment Outcome<br/>Trypanocidal Agents--administration & dosage<br/>Trypanosomiasis, African--complications